Protocol to Validate the Performance of the LifeKit® Prevent Colorectal Neoplasia Test for CRC Screening

NCT04693546 · Status: SUSPENDED · Type: OBSERVATIONAL · Enrollment: 12000

Last updated 2025-09-26

No results posted yet for this study

Summary

The purpose of this study is to determine the sensitivity and specificity for LifeKit Prevent Colorectal Neoplasia Test for colorectal cancer (CRC) and for adenoma, including advanced adenoma.

Conditions

Interventions

DIAGNOSTIC_TEST

LifeKit Prevent Colorectal Neoplasia Test

Procedure: Colonoscopy

DIAGNOSTIC_TEST

FIT Test

Procedure: Colonoscopy

Sponsors & Collaborators

  • Metabiomics Corp

    lead INDUSTRY

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2026-03-01
Primary Completion
2027-12-01
Completion
2028-03-01

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04693546 on ClinicalTrials.gov